Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation.

Barash, Galia; Bassan, Haim; Livne, Ayelet; Benyamini, Lilach; Heyman, Eli; Bowman, Pamela; Rachmiel, Marianna

Barash, Galia; Bassan, Haim; Livne, Ayelet; Benyamini, Lilach; Heyman, Eli; Bowman, Pamela; Rachmiel, Marianna.

Affiliation

Barash G; Pediatric Endocrinology and Diabetes Institute Shamir Medical Center, 70300, Zerifin, Israel.
Bassan H; Pediatric Neurology and Development Center Shamir Medical Center, Tel Aviv, Israel.
Livne A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Benyamini L; Neonatal Intensive Care Unit Shamir Medical Center, Tel Aviv, Israel.
Heyman E; Genetic Institute Shamir Medical Center, Tel Aviv, Israel.
Bowman P; Pediatric Neurology and Development Center Shamir Medical Center, Tel Aviv, Israel.
Rachmiel M; University of Exeter Medical School, Exeter, UK.

Acta Diabetol ; 58(12): 1665-1672, 2021 Dec.

Article in En | MEDLINE | ID: mdl-34272607

Subject(s)

Diabetes Mellitus; Potassium Channels, Inwardly Rectifying/genetics; Diabetes Mellitus/drug therapy; Diabetes Mellitus/genetics; Heterozygote; Humans; Hypoglycemic Agents; Infant, Newborn; Male; Mutation; Prednisolone; Sulfonylurea Compounds

Key words

Diabetes mellitus; Epilepsy; Neonatal; Sulfonylurea

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Potassium Channels, Inwardly Rectifying / Diabetes Mellitus Type of study: Guideline / Prognostic_studies Limits: Humans / Male / Newborn Language: En Journal: Acta Diabetol Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Israel Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google